Table 5.
Characteristics of adults in the study population on ART, at treatment initiation, by sex
Men | Women | |||
---|---|---|---|---|
N | % | N | % | |
Age group | ||||
15–29 | 29 | 13.18 | 150 | 32.05 |
30–44 | 109 | 49.55 | 233 | 49.79 |
45–59 | 48 | 21.82 | 51 | 10.90 |
WHO stage | ||||
1 | 34 | 15.45 | 55 | 11.75 |
2 | 38 | 17.27 | 93 | 19.87 |
3 | 46 | 20.91 | 75 | 16.03 |
4 | 9 | 4.09 | 27 | 5.77 |
CD4 group | ||||
<50 | 26 | 11.82 | 47 | 10.04 |
50–199 | 71 | 32.27 | 137 | 29.27 |
200+ | 26 | 11.82 | 62 | 13.25 |
Year | ||||
2005 | 29 | 13.18 | 41 | 8.76 |
2006 | 30 | 13.64 | 69 | 14.74 |
2007 | 42 | 19.09 | 88 | 18.80 |
2008 | 55 | 25.00 | 116 | 24.79 |
2009 | 64 | 29.09 | 154 | 32.91 |
Total | 220 | 100.00 | 468 | 100.00 |
ART, antiretroviral therapy.